Benvenuto in INNODIA

DE
- Deutsch
DK
- Dansk
EN
- English
FI
- Suomi
FR
- Français
IT
- Italiano
NL
- Nederlands
NO
- Norsk
PL
- Polskie
SE
- Svenska
SI
- Slovenščina

Members area
Data warehouse

Clinical Trials

New diagnosis Ver-A-T1D
New diagnosis MELD-ATG
New diagnosis IMPACT
New diagnosis CFZ533

Panoramica del progetto
Informazioni sul diabete tipo 1
Centri clinici
Faces of Innodia
Notizie ed eventi
Pubblicazioni
Opportunità di lavoro
Members area
Data warehouse
Contact
Clinical Trials
HARVEST
Events
Media
Social Links
- Twitter
- LinkedIn
IT

Con il tuo aiuto,
possiamo combattere il diabete di tipo uno

Se un Suo parente prossimo è affetto da T1D, è anche Lei a rischio?

News:

First positive data in the IMPACT trial

Happy New Year!

What does Innodia mean?

Cosa significa INNODIA?

For Type 1 Diabetes patients

Per i pazienti con diabete tipo 1

For Type 1 Diabetes patients

Participant Spotlight

The Faces of Innodia

Discover all Videos

Clinical Trials

For patient relatives

Per i parenti dei pazienti

For researchers

Per i ricercatori

INNODIA Timeline

2015

November
INNODIA consortium launched

2016

November
INNODIA recruits first newly diagnosed T1D subject on World Diabetes Day

2017

September
Introduction of Delta cartoon, children’s comic booklet and cartoon video by PAC

December
Recruitment capacity extension by Satellites

2018

May
1000 participants recruited

2019

January
50 publications

April
First T1D subject completed 24 mth program

June
Analysis starts of the first 100 people with newly diagnosed T1D

November
3000 participants and counting

December
INNODIA
HARVEST accepted; 4 new academic and 2 industry partners (Novartis, Imcyse) join consortium

2020

February
EMA advises positive on INNODIA's Master Protocol

June
Kick off meeting INNODIA HARVEST

December
• Start of clinical trials
• First patient treated in MELD-ATG

2021

All year
100 years discovery of Insulin

February
• First patient treated in IMPACT study
• First Ver-A-T1D randomisation - Graz
• First patient treated in INNODIA with Iscalimab

September
IMPACT Interim analysis of step 1

2022

January
Start IMPACT step 2 (including adolescents)

February
Last participants included in MELD-ATG

September
Final visit of last participant Ver-A-T1D

October
Last participants included in IMPACT (Step 2 – adults & adolescents)

2023

Results of first
clinical trial

Privacy policy Imprint© Innodia 2022

By using this website, you agree to the use of cookies.
For more information visit: Privacy policy